Highly Stretchable Strain Sensor for Human Motion Monitoring

    公开(公告)号:US20190145752A1

    公开(公告)日:2019-05-16

    申请号:US16300010

    申请日:2017-05-09

    Abstract: The present disclosure provides a simple method to assemble a highly stretchable and highly sensitive strain sensor. Carbon nanofibers prepared by electrospinning of PAN followed by stabilization and carbonization, are sandwiched in two layers of elastomer PU. The CNFs/PU strain sensor shows large strain range of 300%, high sensitivity with gauge factor up to 72.5, and superior stability and durability during 8000 cycles of stretch/release. These parameters meet the intended objectives of the present disclosure and distinguish the present disclosure from the piezoresistive strain sensors reported in the art. Additionally, the CNFs/PU strain sensor shows fast, stable and reproducible responses following the bending movement of fingers, wrists, and elbows. A flexible CNFs/PU strain sensor with the properties disclosed herein can have broad applications in wearable devices for human motion monitoring.

    Curcuminoid complexes with enhanced stability, solubility and/or bioavailability
    56.
    发明授权
    Curcuminoid complexes with enhanced stability, solubility and/or bioavailability 有权
    具有增强的稳定性,溶解度和/或生物利用度的曲霉类复合物

    公开(公告)号:US09504754B2

    公开(公告)日:2016-11-29

    申请号:US14213063

    申请日:2014-03-14

    CPC classification number: A61K47/48176 A61K31/12 A61K47/58

    Abstract: Methods and materials relating to a medicament preparation comprising a curcuminoid component and a euradit component provided as a curcuminoid-eudragit complex, which enhance the bioavailability of the curcumin component and are useful for the treatment of various diseases including cancer, neurodegeneration, inflammation, and immunodeficiency. In some aspects, the curcuminoid component comprises curcumin to prepare a curcumin-eudragit complex and a medicament comprising curcumin-eudragit complexes.

    Abstract translation: 涉及一种药物制剂的方法和材料,所述药物制剂包含姜黄素组分和作为姜黄素 - 黑曲霉复合物提供的euradit组分,其增强姜黄素组分的生物利用度,并且可用于治疗各种疾病,包括癌症,神经变性,炎症和免疫缺陷 。 在一些方面,姜黄素组分包含姜黄素以制备姜黄素 - udragit复合物和包含姜黄素 - udragit复合物的药物。

    PHYSIOLOGICALLY-RELEVANT, SERUM-FREE IN VITRO ANGIOGENESIS PLATFORM

    公开(公告)号:US20250084356A1

    公开(公告)日:2025-03-13

    申请号:US18725006

    申请日:2023-01-06

    Abstract: A custom platform is developed that is capable of culturing endothelial cells three-dimensionally while inducing physiological stimuli on the cells. A model includes serum-free conditions, allowing more quantifiable angiogenesis studies that investigate the dose dependent effects of various growth factors. Angiogenesis plays a critical role during development, wound healing, and disease; therefore, further investigation of the pathway has broad implications. Also, the development of in vitro vascularized tissue models via angiogenesis provides the ability to investigate endothelial responses after exposure to nanoparticles and mechanisms of drug delivery.

Patent Agency Ranking